Nuo Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Nuo Therapeutics generated cash of -$3,167,782, which is more than the previous year. Cash used in financing activities reached the amount of $1,997,500 last year. Net change in cash is therefore -$1,177,527.
Cash Flow
| 2014 | -17.42M | -349.19K | 30.43M |
|---|---|---|---|
| 2015 | -14.39M | -629.39K | 0 |
| 2016 | -10.92M | 100K | 12.52M |
| 2017 | -4.90M | 55.41K | 2.92M |
| 2018 | -874.38K | 2K | 815.8K |
| 2019 | -4.16K | 0 | 305K |
| 2020 | -9.84K | 0 | 195K |
| 2021 | -13.00K | 0 | 1.37T |
| 2022 | -3.70M | -59.99K | 4.45M |
| 2023 | -3.16M | -7.24K | 1.99M |
AURX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.10M | 1.41M | 161.43K | 161.43K | 161.43K | 693.51K | 2.62M | 975.76K | 15.94M | 3.28M |
Operating activities | ||||||||||
Net income | -3.17M | -3.17M | -19.01K | -12.26K | -5.72K | -1.54M | -14.97M | 22.47M | -52.80M | -18.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 105.25K | 74.08K | 0 | 0 | 89.85K | 102.19K | 1.11M | 1.22M | 740.97K | 613.5K |
Stock-based compensation expense | 21.74K | 9.14K | 13.93K | 333.62K | 50K | 0 | 53.52K | 130.08K | 782.75K | 1.27M |
| Deferred income tax benefit | 21.74K | 9.14K | 13.93K | 333.62K | 50K | 0 | 53.52K | 130.08K | 782.75K | 1.27M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -318.38K | -92.32K | 0 | 0 | 22.17K | 331.82K | 277.08M | 310.57K | 695.61B | 2.00T |
Inventories | 14.34K | -240.00K | 0 | 0 | 25.34K | -5.32K | 19.35K | 84.53K | 271.99K | 464.88K |
Accounts payable | -3.18K | 17.58K | 7.51K | 3.92K | 1.55K | 57.04K | -12.33K | -459.59K | -810.97K | -1.47M |
Cash generated by operating activities | -3.16M | -3.70M | -13.00K | -9.84K | -4.16K | -874.38K | -4.90M | -10.92M | -14.39M | -17.42M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -7.24K | -59.99K | 0 | 0 | 0 | 0 | 0 | 0 | -698.17K | -482.96K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 2K | 1.91K | 100K | 68.77K | 133.76K |
Cash generated by investing activities | -7.24K | -59.99K | 0 | 0 | 0 | 2K | 55.41K | 100K | -629.39K | -349.19K |
Financing activities | ||||||||||
Common Stock Issued | 1.99M | 4.45M | 1.37M | 195K | 0 | 500K | 2.92M | 7.05M | 0 | 3.66M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | -471 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -315.8K | 0 | -5.47M | 0 | -6.20M |
Cash used in financing activities | 1.99M | 4.45M | 1.37T | 195K | 305K | 815.8K | 2.92M | 12.52M | 0 | 30.43M |
Net Change In Cash | -1.17M | 691.63K | -13.00K | -9.84K | -4.16K | -56.58K | -1.92M | 1.69M | -15.02M | 12.65M |
Cash at end of period | 928.68K | 2.10M | 148.43K | 151.58K | 157.26K | 636.92K | 693.51K | 2.67M | 922.31K | 15.94M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |